BNP Paribas Issuance (P16JU8) Börsenkurse

Form 4 - Statement of changes in beneficial ownership of securities

Form 424B2 - Prospectus [Rule 424(b)(2)]

Quest Diagnostics Prices $1.85 Billion of Senior Notes

Quest Diagnostics Prices $1.85 Billion of Senior Notes PR Newswire SECAUCUS, N.J., Aug. 15, 2024 SECAUCUS, N.J., Aug. 15, 2024 /PRNewswire/ -- Quest Diagnostics Incorporated (NYSE: DGX) (the...

Form FWP - Filing under Securities Act Rules 163/433 of free writing prospectuses

Form 424B2 - Prospectus [Rule 424(b)(2)]

questhealth.com Introduces 13 New Blood Tests to Identify Micronutrient Deficiencies

questhealth.com Introduces 13 New Blood Tests to Identify Micronutrient Deficiencies PR Newswire SECAUCUS, N.J., Aug. 15, 2024 Lab tests offer insights for individuals who may experience...

Quest Diagnostics Declares Quarterly Cash Dividend

Quest Diagnostics Declares Quarterly Cash Dividend PR Newswire SECAUCUS, N.J., Aug. 14, 2024 SECAUCUS, N.J., Aug. 14, 2024 /PRNewswire/ -- Quest Diagnostics (NYSE: DGX), a leader in diagnostic...

Pregnant Women Undertested for STIs, Finds Quest Diagnostics Health Trends® Study of Over 4 Million Pregnancies

Pregnant Women Undertested for STIs, Finds Quest Diagnostics Health Trends® Study of Over 4 Million Pregnancies PR Newswire SECAUCUS, N.J., Aug. 12, 2024 One in three women who tested positive...

Quest Diagnostics Named a "Best Place to Work for Disability Inclusion" for Seventh Straight Year

Quest Diagnostics Named a "Best Place to Work for Disability Inclusion" for Seventh Straight Year PR Newswire SECAUCUS, N.J., Aug. 1, 2024 Quest achieves top score of 100 on 2024...

Haystack Oncology and Université de Montréal's affiliated hospital research centre, the CRCHUM, to Deploy Haystack MRD™ Technology in Research Study for Metastatic Colorectal Cancer

Haystack Oncology and Université de Montréal's affiliated hospital research centre, the CRCHUM, to Deploy Haystack MRD™ Technology in Research Study for Metastatic Colorectal Cancer PR...